Literature DB >> 32600853

Cochlear detoxification: Role of alpha class glutathione transferases in protection against oxidative lipid damage, ototoxicity, and cochlear aging.

Shinichi Someya1, Mi-Jung Kim2.   

Abstract

Age-related hearing loss (AHL) is the most common form of hearing impairment. AHL is thought to be a multifactorial condition resulting from the interaction of numerous causes including aging, genetics, exposure to noise, and exposure to endogenous and exogenous toxins. Cells possess many detoxification enzymes capable of removing thousands of cytotoxic xenobiotics and endogenous toxins such as 4-hydroxynonenal (4-HNE), one of the most abundant cytotoxic end products of lipid peroxidation. The cellular detoxification system involves three phases of enzymatic detoxification. Of these, the glutathione transferase (GST) detoxification system converts a toxic compound into a less toxic form by conjugating the toxic compound to reduced glutathione by GST enzymes. In this review, we describe the current understanding of the cochlear detoxification system and examine the growing link between GST detoxification, oxidative lipid damage, ototoxicity, and cochlear aging with a particular focus on the alpha-class GSTs (GSTAs). We also describe how exposure to ototoxic drugs, exposure to noise, or aging results in increased 4-HNE levels, how 4-HNE damages various cell components under stress conditions, and how GSTAs detoxify 4-HNE in the auditory system.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4-HNE; Aging; Cochlea; Detoxification; Estrogen; GST; NRF2

Mesh:

Substances:

Year:  2020        PMID: 32600853      PMCID: PMC7704621          DOI: 10.1016/j.heares.2020.108002

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  97 in total

1.  Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males.

Authors:  Consuelo Borrás; Juan Sastre; David García-Sala; Ana Lloret; Federico V Pallardó; José Viña
Journal:  Free Radic Biol Med       Date:  2003-03-01       Impact factor: 7.376

Review 2.  Clinical implications of pharmacogenetics for glaucoma therapeutics.

Authors:  N C McLaren; S E Moroi
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

Review 3.  Knockout and transgenic mice in glutathione transferase research.

Authors:  Colin J Henderson; C Roland Wolf
Journal:  Drug Metab Rev       Date:  2011-03-22       Impact factor: 4.518

4.  Thyroid hormone and estradiol have overlapping effects on kidney glutathione S-transferase-α gene expression.

Authors:  Larissa C Faustino; Norma A S Almeida; Guilherme F Pereira; Rafael G Ramos; Raquel M Soares; Marcelo M Morales; Carmen C Pazos-Moura; Tania M Ortiga-Carvalho
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-24       Impact factor: 4.310

5.  Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury.

Authors:  D J Harrison; R Kharbanda; D S Cunningham; L I McLellan; J D Hayes
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

6.  Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue.

Authors:  Domenico Lapenna; Giuliano Ciofani; Gabriele Obletter; Sante Donato Pierdomenico; Francesco Cipollone; Roberto Cotellese; Massimo Cieri; Ettore Porreca
Journal:  Exp Gerontol       Date:  2018-11-23       Impact factor: 4.032

7.  Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells.

Authors:  J Z Cheng; S S Singhal; M Saini; J Singhal; J T Piper; F J Van Kuijk; P Zimniak; Y C Awasthi; S Awasthi
Journal:  Arch Biochem Biophys       Date:  1999-12-01       Impact factor: 4.013

Review 8.  Estrogen receptors, the hippocampus, and memory.

Authors:  Linda A Bean; Lara Ianov; Thomas C Foster
Journal:  Neuroscientist       Date:  2014-02-07       Impact factor: 7.519

Review 9.  Ototoxicity.

Authors:  L P Rybak; V Ramkumar
Journal:  Kidney Int       Date:  2007-07-25       Impact factor: 10.612

10.  Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.

Authors:  S Kohn; M Fradis; H Pratt; J Zidan; L Podoshin; E Robinson; I Nir
Journal:  Laryngoscope       Date:  1988-08       Impact factor: 3.325

View more
  3 in total

1.  Longitudinal Study of Analgesic Use and Risk of Incident Persistent Tinnitus.

Authors:  Sharon G Curhan; Jordan Glicksman; Molin Wang; Roland D Eavey; Gary C Curhan
Journal:  J Gen Intern Med       Date:  2022-02-07       Impact factor: 6.473

Review 2.  Oxidative Stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the Pathogenesis and Treatment of Aging-related Diseases.

Authors:  Yanling Li; Tingting Zhao; Jiaxin Li; Mengyao Xia; Yuling Li; Xiaoyu Wang; Chuanguo Liu; Tingting Zheng; Renjie Chen; Dongfang Kan; Yicheng Xie; Jingjie Song; Yu Feng; Tiangui Yu; Peng Sun
Journal:  J Immunol Res       Date:  2022-03-23       Impact factor: 4.818

Review 3.  Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity.

Authors:  Vickram Ramkumar; Debashree Mukherjea; Asmita Dhukhwa; Leonard P Rybak
Journal:  Antioxidants (Basel)       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.